Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Proton pump inhibitors, adverse events and increased risk of mortality
Aitor Lanas-Gimeno, Gonzalo Hijos, Fernando Laņas
Expert Opinion on Drug Safety (2019) Vol. 18, Iss. 11, pp. 1043-1053
Closed Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Consensus for the management of pancreatic exocrine insufficiency: UK practical guidelines
Mary Phillips, Andrew D. Hopper, John Leeds, et al.
BMJ Open Gastroenterology (2021) Vol. 8, Iss. 1, pp. e000643-e000643
Open Access | Times Cited: 105
Association of proton‐pump inhibitor use with adverse health outcomes: A systematic umbrella review of meta‐analyses of cohort studies and randomised controlled trials
Sajesh K. Veettil, Saranrat Sadoyu, Elizabeth Bald, et al.
British Journal of Clinical Pharmacology (2021) Vol. 88, Iss. 4, pp. 1551-1566
Open Access | Times Cited: 38
Proton Pump Inhibitors, Kidney Damage, and Mortality: An Updated Narrative Review
Amber N. Edinoff, Natalie W. Wu, Katelyn Parker, et al.
Advances in Therapy (2023) Vol. 40, Iss. 6, pp. 2693-2709
Open Access | Times Cited: 13
Xiangsha Liujunzi Tang Alleviates Indomethacin-Induced Gastric Mucosal Injury by Inhibiting Nlrp3 Inflammasome-Mediated Pyroptosis in Rats
Qifang Sun, Xiaowei Yi, Shunhua Zhou, et al.
(2025)
Closed Access
Proton Pump Inhibitor Use and Its Association with Lung Cancer Likelihood and Mortality: A Nationwide Nested Case–Control Study in Korea
Mi Jung Kwon, Ho Suk Kang, Hyo Geun Choi, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 877-877
Open Access
Association of Proton Pump Inhibitor Use With All-Cause and Cause-Specific Mortality
Chun‐Han Lo, Peiyun Ni, Yan Yan, et al.
Gastroenterology (2022) Vol. 163, Iss. 4, pp. 852-861.e2
Open Access | Times Cited: 21
Analysis of deprescription strategies of proton pump inhibitors in primary care: a narrative review
Miguel Del-Pino, Emílio J. Sanz
Primary Health Care Research & Development (2023) Vol. 24
Open Access | Times Cited: 11
P-CAB versus PPI in the eradication of Helicobacter pylori: a systematic review and network meta-analysis
Yutong Jiang, Rongrong Zhang, Yuxuan Fang, et al.
Therapeutic Advances in Gastroenterology (2024) Vol. 17
Open Access | Times Cited: 4
Esomeprazole overcomes paclitaxel‐resistance and enhances anticancer effects of paclitaxel by inducing autophagy in A549/Taxol cells
Zhaoshi Bai, Nianyang Ding, Jianjuan Ge, et al.
Cell Biology International (2020) Vol. 45, Iss. 1, pp. 177-187
Closed Access | Times Cited: 30
The pharmacotherapeutic management of gastroesophageal reflux disease (GERD)
Nicolas Chapelle, Inès Ben Ghezala, Alan Barkun, et al.
Expert Opinion on Pharmacotherapy (2020) Vol. 22, Iss. 2, pp. 219-227
Closed Access | Times Cited: 29
Proton Pump Inhibitors and Cancer Risk
Manli Zhang, Yuxin Fan, Rui Meng, et al.
American Journal of Clinical Oncology (2022) Vol. 45, Iss. 11, pp. 475-485
Closed Access | Times Cited: 17
The Use of Proton Pump Inhibitors May Increase Symptoms of Muscle Function Loss in Patients with Chronic Illnesses
Paulien Vinke, Evertine Wesselink, A.C.B. van Orten-Luiten, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 1, pp. 323-323
Open Access | Times Cited: 26
Do proton pump inhibitors increase mortality? A systematic review and in‐depth analysis of the evidence
Mohamed Ben‐Eltriki, Carolyn J. Green, Malcolm Maclure, et al.
Pharmacology Research & Perspectives (2020) Vol. 8, Iss. 5
Open Access | Times Cited: 22
Taxifolin and gastro-adhesive microparticles containing taxifolin promotes gastric healing in vivo, inhibits Helicobacter pylori in vitro and proton pump reversibly in silico
Fernanda Cristina Stenger Moura, Valdir Cechinel Filho, Francesco Greco, et al.
Chemico-Biological Interactions (2021) Vol. 339, pp. 109445-109445
Closed Access | Times Cited: 17
Use of Proton Pump Inhibitors in Hungary: Mixed-Method Study to Reveal Scale and Characteristics
Mária Matúz, Ria Benkő, Zsófia Engi, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 17
Proton pump inhibitors in systemic sclerosis: a reappraisal to optimise treatment of gastro-oesophageal reflux disease
Michael Hughes, Yannick Allanore, Murray Baron, et al.
The Lancet Rheumatology (2022) Vol. 4, Iss. 11, pp. e795-e803
Open Access | Times Cited: 10
Personalized Treatments Based on Laryngopharyngeal Reflux Patient Profiles: A Narrative Review
Jérôme R. Lechien
Journal of Personalized Medicine (2023) Vol. 13, Iss. 11, pp. 1567-1567
Open Access | Times Cited: 5
Binding of omeprazole to protein targets identified by monoclonal antibodies
Naw May Pearl Cartee, Michael M. Wang
PLoS ONE (2020) Vol. 15, Iss. 9, pp. e0239464-e0239464
Open Access | Times Cited: 13
Polypharmacy in Patients With Inflammatory Bowel Disease
Francisco Mesonero, Cristina Férnandez, E Sánchez-Rodríguez, et al.
Journal of Clinical Gastroenterology (2021) Vol. 56, Iss. 3, pp. e189-e195
Open Access | Times Cited: 12
Treating and Managing Laryngopharyngeal Reflux Disease in the Over 65s: Evidence to Date
Jérôme R. Lechien
Clinical Interventions in Aging (2022) Vol. Volume 17, pp. 1625-1633
Open Access | Times Cited: 8
Successful deprescribing of proton pump inhibitors with a patient-centered process: the DESPIBP Project
Lamuela L. J. Calvo, P. Camara, Mónica Llorente Barrio, et al.
European Journal of Clinical Pharmacology (2021) Vol. 77, Iss. 12, pp. 1927-1933
Closed Access | Times Cited: 11
The impact of pharmacist intervention on the intravenous-to-oral switch therapy of proton pump inhibitors in cardiovascular surgery
Jianan Bao, Ling Zhou, Mengying Xu, et al.
Expert Opinion on Drug Safety (2023) Vol. 22, Iss. 7, pp. 611-619
Closed Access | Times Cited: 4
Proton pump inhibition for secondary hemochromatosis in hereditary anemia: a phase III placebo‐controlled randomized cross‐over clinical trial
Annelies J. van Vuren, Jean‐Louis Kerkhoffs, Saskia E.M. Schols, et al.
American Journal of Hematology (2022) Vol. 97, Iss. 7, pp. 924-932
Open Access | Times Cited: 7
False-positive fecal immunochemical test results in colorectal cancer screening and gastrointestinal drug use
María José Domper-Arnal, Sandra G. García, Sonia Hermoso‐Durán, et al.
International Journal of Colorectal Disease (2021) Vol. 36, Iss. 9, pp. 1861-1869
Closed Access | Times Cited: 8
Impact of proton pump inhibitor management committee’s multifaceted interventions on acid suppressant prescribing patterns in outpatient and emergency departments
Lu Liu, Yongqi Yu, Qingze Fan, et al.
BMC Health Services Research (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top